✦ LIBER ✦

SLV313 is a dopamine D2 receptor antagonist and serotonin 5-HT1A receptor agonist: In vitro and in vivo neuropharmacology

✍ Scribed by J. Glennon; A.C. McCreary; E. Ronken; R. Siarey; M.B. Hesselink; R. Feenstra; B. Van Vliet; S.K. Long; C.G. Kruse

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The 5-HT4 receptor agonist, tegaserod, i

✍ D T Beattie; J A M Smith; D Marquess; R G Vickery; S R Armstrong; T Pulido-Rios; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 298 KB

P2.104 Effects of pardoprunox (SLV308),

✍ C. Bétry; A. Etievant; L. Lambas-Senas; A. McCreary; N. Haddjeri 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

SLV310, a molecule combining potent dopa

✍ M.B. Hesselink; B. Van Vliet; C.G. Kruse; S.K. Long 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 143 KB

SLV310, a molecule combining potent dopa

✍ M.B. Hesselink; B. Van Vliet; C.G. Kruse; S.K. Long 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 114 KB

In vivo dopamine-D2 and serotonin-5-HT2

✍ T. sumiyoshi; H. Kido; H. Sakamoto; K. Urasaki; K. Suzuki; N. Yamaguchi; H. Mori 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 511 KB

F15063, a potential antipsychotic with d

✍ Marie-Bernadette Assié; Ouissame Mnie-Filali; Véronique Ravailhe; Christelle Ben 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 908 KB